Cargando…
Exosomes in craniofacial tissue reconstruction
BACKGROUND: Mesenchymal stem cell (MSC) therapy gained interest among scientists following the discovery of its therapeutic potential. However, their clinical use has been hindered due to their immunogenicity and tumorigenicity. Relatively recently, it has been unveiled that the mechanism by which M...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399332/ https://www.ncbi.nlm.nih.gov/pubmed/35999408 http://dx.doi.org/10.1186/s40902-022-00357-3 |